Status:
RECRUITING
Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty
Lead Sponsor:
Hospital for Special Surgery, New York
Conditions:
Chronic Pain
Opioid Use
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The goal of this interventional clinical trial is to assess opioid consumption 24-48 hrs post anesthesia block among patients undergoing total knee arthroplasty. The main question it aims to answer is...
Detailed Description
The purpose of this study is to see if adding a continuous ACB catheter will extend analgesia beyond the 24-48 hour period. This interventional clinical trial will assess opioid consumption in patient...
Eligibility Criteria
Inclusion
- Patients with osteoarthritis scheduled for a primary total knee arthroplasty with a participating surgeon
- Age 18 to 75 years
- Planned use of regional anesthesia
- Ability to follow study protocol
- English speaking (secondary outcomes include questionnaires validated in English only)
- Patients of participating surgeons: Drs. Mayman, Jerabek, Westrich, Su, Della Valle, Alexiades
- Lives within one hour of the hospital
- Has a smartphone
Exclusion
- Hepatic or renal insufficiency
- Younger than 18 years old and older than 65
- Patients undergoing general anesthesia
- Allergy or intolerance to one of the study medications
- BMI \> 40
- Diabetes
- ASA of III,IV
- Chronic gabapentin/pregabalin use (regular use for longer than 3 months)
- PCS \> 30
- Chronic opioid use (taking opioids for longer than 3 months, or daily oral morphine equivalent of \>5mg/day for one month)
- Patients with severe valgus deformity or flexion contracture
- Patients unable to follow home catheter instructions and unwilling to go home with an infusing catheter
- Patients who have no home caregivers in the event if a catheter is to be sent home with the patient
- Patients with planned stay at rehab facility
Key Trial Info
Start Date :
June 12 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT05981105
Start Date
June 12 2023
End Date
January 1 2025
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021